Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compositions and methods for treating gram positive bacterial infection in a mammalian subject

A Gram-positive, bacterial infection technology, applied in the direction of botanical equipment and methods, drug combinations, chemical instruments and methods, etc., can solve the problem that the role of antibacterial defense has not yet been established in the body

Inactive Publication Date: 2009-10-28
THE SCRIPPS RES INST
View PDF59 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, their role for antimicrobial defense has not been established in vivo and their biosynthesis is not regulated by microbial stimuli

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for treating gram positive bacterial infection in a mammalian subject
  • Compositions and methods for treating gram positive bacterial infection in a mammalian subject
  • Compositions and methods for treating gram positive bacterial infection in a mammalian subject

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0058] Methods for making other antibodies and antibody fragments are known in the art. For example, although F v two domains of fragment V L and V H Encoded by two separate genes, they can be separated by V through recombinant methods or synthetic linkers. L and V H Domains pair to form single protein chains of monovalent molecules (termed single-chain F v (scF v ); See Bird et al., Science 242:423-426,1988; Huston et al., Proc.Natl.Acad.Sci.USA 85:5879-5883,1988; Colcher et al., Ann.NY Acad.Sci.880: 263-80, 1999; and Reiter, Clin. Cancer Res. 2:245-52, 1996).

[0059] Techniques for preparing single-chain antibodies are described in U.S. Pat. Nos. 4,946,778 and 4,704,692. Such single chain antibodies are encompassed within the term "antigen-binding fragment" of an antibody. These antibody fragments can be obtained by conventional techniques known to those of ordinary skill in the art, and the fragments can be screened for use by screening intact antibodies. In addit...

Embodiment 1

[0312] Flake: a visible phenotypic variant with associated immunodeficiency

[0313] ENU-induced germline mutations were used in an effort to identify genes required for general immune function. A total of 20,792F1 and 33,202F3 animals were screened for visible and immune phenotypes. Among them, a recessive mutation known as "flake" (flk) was found to cause progressive hair loss and chronic exfoliative dermatitis. These features appear at weaning age and are more pronounced in older animals ( figure 1 ). Visible disruption of epidermal integrity and spontaneous skin infections requiring antibiotic treatment prompted us to examine the integrity of innate immune function in these mice.

[0314] figure 1 Visible phenotypes observed in flake mutant mice are shown. A. 6 week old mouse B. 8 month old mouse C. Ocular infection in 8 month old mouse D. Magnification of mouse in B to highlight severe dermatitis.

Embodiment 2

[0316] Persistent Streptococcus pyogenes and Staphylococcus aureus skin infections in flk / flk mutant mice

[0317] mutant mice

[0318] The gram-positive cocci Streptococcus pyogenes and Staphylococcus aureus are the main pathogens of impetigo, cellulitis and wound infections in humans. Guay, Expert. Opin. Pharmacother. 4:1259-1275, 2003; Hedrick, Paediatr. Drugs 1:35-46, 2003. Experimental full-thickness skin infection in murine models can be reliably established by direct subcutaneous injection with fine-pitch needles, thereby overcoming the need for trauma and poor infectivity and reproducibility associated with patch vaccination. Bunce et al., Infect. Immun. 60:2636-2640, 1992; Kraft et al., Infect. Immun. 52:707-713, 1986; Nizet et al., Nature 414:454-457, 2001.

[0319] Luminescently labeled S. pyogenes and S. aureus and E. coli strains, each constitutively expressing the bacterial luciferase gene operon from Achromobacter, can be used. Kuklin et al., Antimicrob Agent...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Compositions and methods are provided for treating Gram positive bacterial infection in a mammalian subject. Compositions and methods are further provided for treating Gram positive bacterial skin infection in the mammalian subject. Compositions and methods are provided that comprise administering to the mammalian subject an effective amount of a compound that activates Scd1 gene expression or activates Scd1 gene product.

Description

[0001] Statement of Government Funding [0002] This invention was made with support from the National Institutes of Health under grant number U54-AI54523. The government has certain rights in this invention. [0003] Cross References to Related Applications [0004] This application claims U.S. Provisional Application 60 / 701,216, filed July 20, 2005, and EMS EV 670672061 US, filed July 19, 2006, entitled "Compositions for the Treatment of Gram-Positive Bacterial Infections in a Mammalian Subject" and Methods", the entire disclosure of which is hereby incorporated by reference. technical field [0005] The present invention generally relates to compositions and methods for treating Gram-positive bacterial infections in mammalian subjects. The invention further relates to compositions and methods for treating Gram-positive bacterial skin infections in mammalian subjects. The compositions and methods further comprise administering to the mammalian subject an effective amount...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A01N63/00C07G11/00
CPCY02A50/30
Inventor 布鲁斯·博伊特勒菲利普·若热尔
Owner THE SCRIPPS RES INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com